Neurochem (NRMX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurochem (NRMX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: MLD38	6/13/2007 11:48:50 AM
	of 54

NRMX: RBC Cap Downgrades Price Target 75% ... from C$7.50 to C$2 a share ... biotech.seekingalpha.com It appears Michael Shulman, ChangeWave BioTech editor, closed his Neurochem ( NRMX ) position in Feb 2007. See: Alzheimer's Disease and Neurochem biotechblitz.com ...For those of you who subscribe to ChangeWave Biotech you are aware I recently closed the position in Neurochem (NRMX) with a nice gain (50% and change) although it was well off the highs for the stock. I want to spend a bit more time explaining why the debate about its Phase III Alzheimer's treatment Alzhemed was making me, and many others, a bit nervous.... AND May have issued a short NRMX in his ChangeWave Shorts newsletter : Using regular Site Search (not the advanced webpage) --- NRMX may have been mentioned in the following : 05/17/2007 Stocks Not Even a Mother Could Love 05/09/2007 Why I Love the Short Side 6 month chart: ( 52 week range = $5.60 - $26.51) finance.yahoo.com One year chart: ( 52 week range = $5.60 - $26.51) finance.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next